Matches in Wikidata for { <http://www.wikidata.org/entity/Q52610085> ?p ?o ?g. }
- Q52610085 description "2018 nî lūn-bûn" @default.
- Q52610085 description "2018年の論文" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年学术文章" @default.
- Q52610085 description "2018年學術文章" @default.
- Q52610085 description "2018年學術文章" @default.
- Q52610085 description "2018年學術文章" @default.
- Q52610085 description "2018年學術文章" @default.
- Q52610085 description "2018年學術文章" @default.
- Q52610085 description "2018년 논문" @default.
- Q52610085 description "article científic" @default.
- Q52610085 description "article scientific" @default.
- Q52610085 description "article scientifique" @default.
- Q52610085 description "articol științific" @default.
- Q52610085 description "articolo scientifico" @default.
- Q52610085 description "artigo científico" @default.
- Q52610085 description "artigo científico" @default.
- Q52610085 description "artigo científico" @default.
- Q52610085 description "artikel ilmiah" @default.
- Q52610085 description "artikull shkencor" @default.
- Q52610085 description "artikulong pang-agham" @default.
- Q52610085 description "artykuł naukowy" @default.
- Q52610085 description "artículo científico publicado en 2018" @default.
- Q52610085 description "artículu científicu" @default.
- Q52610085 description "bilimsel makale" @default.
- Q52610085 description "bài báo khoa học" @default.
- Q52610085 description "naučni članak" @default.
- Q52610085 description "scienca artikolo" @default.
- Q52610085 description "scientific article published on 31 March 2018" @default.
- Q52610085 description "scientific article published on 31 March 2018" @default.
- Q52610085 description "scientific article published on 31 March 2018" @default.
- Q52610085 description "teaduslik artikkel" @default.
- Q52610085 description "tieteellinen artikkeli" @default.
- Q52610085 description "tudományos cikk" @default.
- Q52610085 description "vedecký článok" @default.
- Q52610085 description "vetenskaplig artikel" @default.
- Q52610085 description "videnskabelig artikel" @default.
- Q52610085 description "vitenskapelig artikkel" @default.
- Q52610085 description "vitskapeleg artikkel" @default.
- Q52610085 description "vědecký článek" @default.
- Q52610085 description "wetenschappelijk artikel" @default.
- Q52610085 description "wissenschaftlicher Artikel" @default.
- Q52610085 description "επιστημονικό άρθρο" @default.
- Q52610085 description "мақолаи илмӣ" @default.
- Q52610085 description "наукова стаття, опублікована в березні 2018" @default.
- Q52610085 description "научна статия" @default.
- Q52610085 description "научная статья" @default.
- Q52610085 description "научни чланак" @default.
- Q52610085 description "научни чланак" @default.
- Q52610085 description "מאמר מדעי" @default.
- Q52610085 description "مقالة علمية نشرت في 31 مارس 2018" @default.
- Q52610085 description "৩১ মার্চ ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q52610085 description "บทความทางวิทยาศาสตร์" @default.
- Q52610085 description "სამეცნიერო სტატია" @default.
- Q52610085 name "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 name "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 type Item @default.
- Q52610085 label "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 label "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 prefLabel "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 prefLabel "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 P1433 Q52610085-D1BB1FF4-546A-4C94-B1EC-ADE708741482 @default.
- Q52610085 P1476 Q52610085-8CB588EC-D7CE-40AF-B24A-4E45E22FA4B7 @default.
- Q52610085 P2093 Q52610085-01AAD4F9-2324-4EB3-8EA2-B7DEB992DF48 @default.
- Q52610085 P2093 Q52610085-0DDFF73C-37E4-4815-B9F4-F61103B866E4 @default.
- Q52610085 P2093 Q52610085-12FB37F0-B881-4C7E-880C-C1708F6D661C @default.
- Q52610085 P2093 Q52610085-2DE7596F-D26E-4531-818C-940AED66F001 @default.
- Q52610085 P2093 Q52610085-3A3391DB-3665-4FC2-AD3D-6EB8FBCFE664 @default.
- Q52610085 P2093 Q52610085-4BA43B64-CDEB-47E9-84DF-8917AA41CB64 @default.
- Q52610085 P2093 Q52610085-989521D1-BD74-44F2-8357-F387C193D15F @default.
- Q52610085 P2093 Q52610085-AD3F89A0-93DF-4731-A695-33700760D6DD @default.
- Q52610085 P2093 Q52610085-F80C76BF-2526-47AC-B52E-737803FBAAA1 @default.
- Q52610085 P31 Q52610085-88E64307-A5D9-43F3-8784-9D419027C79D @default.
- Q52610085 P356 Q52610085-33B7C76E-FA4E-413D-B78A-0557A504F4E0 @default.
- Q52610085 P407 Q52610085-DD84743A-671E-4D6F-8DFB-80095E6DAA48 @default.
- Q52610085 P577 Q52610085-4E0E274B-AA59-4845-ACA4-762196BACD15 @default.
- Q52610085 P698 Q52610085-61829637-C7AC-421F-8BC2-097A9DEDD1C9 @default.
- Q52610085 P8608 Q52610085-7282B67A-A770-4F1B-9151-408E68AB7858 @default.
- Q52610085 P921 Q52610085-9410B846-94C6-49DB-B991-F98D842EB1A4 @default.
- Q52610085 P921 Q52610085-B69ABAE2-C6AF-402E-89D0-321E4CBA5651 @default.
- Q52610085 P356 J.JAAD.2018.03.040 @default.
- Q52610085 P698 29614243 @default.
- Q52610085 P1433 Q15757046 @default.
- Q52610085 P1476 "Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results of two Phase 3 randomized controlled trials." @default.
- Q52610085 P2093 "David M Pariser" @default.
- Q52610085 P2093 "Gina Martin" @default.
- Q52610085 P2093 "Jeffrey L Sugarman" @default.
- Q52610085 P2093 "Linda Stein Gold" @default.
- Q52610085 P2093 "Mark G Lebwohl" @default.
- Q52610085 P2093 "Radhakrishnan Pillai" @default.
- Q52610085 P2093 "Robert Israel" @default.
- Q52610085 P2093 "Tage Ramakrishna" @default.
- Q52610085 P2093 "Tina Lin" @default.
- Q52610085 P31 Q13442814 @default.
- Q52610085 P356 "10.1016/J.JAAD.2018.03.040" @default.
- Q52610085 P407 Q1860 @default.